期刊文献+

老年慢性阻塞性肺疾病血清D-二聚体变化的临床意义 被引量:4

The Changes of Serum D-dimer in The Elderly Patients with Chronic Obstructive Pulmonary Disease and Its Significance
暂未订购
导出
摘要 目的探讨老年慢性阻塞性肺疾病急性加重期(AECOPD)治疗前后D-二聚体变化及临床意义。方法随机选取40例老年慢性阻塞性肺疾病急性加重期患者,检测治疗前后血清D-二聚体含量,选取40名健康体检者为对照组。同时测定老年AECOPD治疗前患者动脉血氧分压,分析血清D-二聚体水平与动脉血氧分压的相关性。结果老年AECOPD患者在治疗前后血清D-二聚体含量均较对照组升高,差异有统计学意义(P<0.05)。老年AECOPD患者在治疗后较治疗前D-二聚体含量明显减少,差异有统计学意义(P<0.05)。老年AECOPD患者血清D-二聚体水平与动脉血氧分压呈负相关(P<0.05)。结论 COPD患者存在血栓前状态,D-二聚体水平可能反映COPD患者病情的严重程度及凝血功能状态。 Objective To investigate the clinical significance of changes of serum D-dimer tor the elderly pataents with a- cute exacerbation of chronic obstructive pulmonary disease (AECOPD)before and after treatment. Methods 40 elderly patients with AECOPD were randomly selected ,The serum D-dimer level of these 40 subjects were determined before and after treatment. 40 healthy persons were selected for the healthy control group. The arterial Pa02 was detected for the elderly patients with AECOPDbefore treatment. The association between serum D-dimer and PaO2 was analyzed. Results The serum D-dimer level in AECOPD group was higher than the control group. The difference was considered significant(P 〈 0.05). The serum D-dimer level with elderly AECOPD patients after treatment was lower than those before treatment (P 〈 0. 05 ). Serum D-dimer level was negatively correlated with PaO 2 (P 〈 0. 05). Conclusion The prothrombotic state probably exists in COPD patients. Serum D-dimer level might reflect the severity of COPD and coagulation status.
出处 《四川医学》 CAS 2015年第5期681-683,共3页 Sichuan Medical Journal
关键词 慢性阻塞性肺疾病 D-二聚体 动脉血氧分压 chronic obstructive pulmonary disease D-dimer PaO2
  • 相关文献

参考文献9

  • 1Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pul- monary disease in China: a large, population-based survey [ J ]. Am J Respir Ctit Care Med ,2007 ,176 :753-756.
  • 2Rabe KF, Hurd S. Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease : GOLD executive summary [ J ]. Am J Respir Crit Care Med ,2007. 176: 532-555.
  • 3GOLD Executive Committee. Global strategy for the diagnosis, manage- ment, and prevention of chronic obstructive pulmonary disease( Revised 2011 ) [ EB/OL]. http ://www. goldcopd, com. 2012.
  • 4Spurzem JR, Rennard SI. Pathogenesis of COPD[ J]. Semin Respir Crit Care Med ,2005,26 : 142-153.
  • 5王少霞,吴海燕.慢性阻塞性肺疾病急性加重期凝血指标的变化[J].临床荟萃,2008,23(13):955-956. 被引量:8
  • 6Riccardo Polosa, Rossella R, Cacciola,et al. Endothelial coagulative ac- tivation during chronic obstructive pulmonary disease exacerbations [ J ]. Haematologica,2008,93 (8) : 1275-1276.
  • 7王卫青,郭俊卿,冯国梁,杨敬平,孙德俊.肺部疾病患者血浆D-二聚体测定的临床意义[J].临床肺科杂志,2004,9(1):41-42. 被引量:5
  • 8吕元文,姜正华,丁平,朱慕云,朱湘平,汤艳.慢性阻塞性肺疾病患者血二氧化碳分压与血浆D-二聚体水平的相关性[J].临床内科杂志,2005,22(7):498-499. 被引量:10
  • 9Sabit R, Thomas P, Shale DJ,et al. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD [ J ]. Chest,2010,138 ( 1 ) :47-51.

二级参考文献10

共引文献20

同被引文献46

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部